The Effect of Therapy on Tumour Vascular Function

References

• Ackerman, N.B., Jacobs, R. Effects of epinephrine and other vasconstrictory agents on intrahepatic tumour blood flow. Microcirculation—on Update, M. Tsuchiya, et al. Elsevier, Amsterdam 1987; 2: 817–818
   Google Scholar
• Baez S. Microcirculation. Annual review of Physiology 1977; 39: 391–415
   PubMedGoogle Scholar
• Balkwill F.R. Cytokines in Cancer Therapy. Oxford University Press, Oxford 1989
   Google Scholar
• Berns M.W., Wile A.G. Hematoporphyrin phototherapy of cancer. Radiotherapy and Oncology 1986; 7: 233–240
   PubMedGoogle Scholar
• Bibby M.C., Double J.A., Loadman P.M., Duke C.V. Reduction of tumour blood flow by flavone acetic acid: a possible component of therapy. Journal of the National Cancer Institute 1989; 81: 216–220
   PubMed Web of Science ®Google Scholar
• Brown, J.M. Exploitation of bioreductive agents with vasoactive drugs. Proceedings of the Eighth International Congress on Radiation Research Proceedings of the Eighth International Congress on Radiation ResearchEdinburghUKE.M. Fielder, et al. Taylor & Francis, London 1987; 719–724
   Google Scholar
• Burton M.A., Gray B.N., Coletti A. Effect of angiotensin II on blood flow in the transplanted sheep squamous cell carcinoma. European Journal of Cancer and Clinical Oncology 1988; 21: 1373–1376
   Google Scholar
• Burton M.A., Gray B.N., Self G.W., Heggie J.C., Townsend P.S. Manipulation of experimental rat and rabbit liver tumour blood flow with angiotensin II. Cancer Research 1985; 45: 5390–5393
   PubMed Web of Science ®Google Scholar
• Capolongo L.S., Balconi G., Ubezio P., Giavazzi R., Taraboletti G., Regonesi A., Yoder O.C., D'Incalci M. Antiproliferative properties of flavone acetic acid (NSC347512) (LM975) a new anticancer agent. European Journal of Cancer and Clinical Oncology 1987; 23: 1529–1535
   PubMedGoogle Scholar
• Chaplin D.J. Hydralazine induced tumour, hypoxia: a potential target for cancer chemotherapy. Journal of the National Cancer Institute 1989; 81: 618–622
   PubMed Web of Science ®Google Scholar
• Chaplin D.J., Durand R.E., Olive P.L. Cell selection from a murine tumour using the fluorescent probe Hoechst 33342. British Journal of Cancer 1985; 51: 569–572
   PubMedGoogle Scholar
• Chaplin D.J., Durand R.E., Olive P.L. Acute hypoxia in tumours: implications for modifiers of radiation effects. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 1279–1282
   PubMed Web of Science ®Google Scholar
• Chaplin D.J., Olive P.L., Durand R.E. Intermittent blood flow in a murine tumour: radiobiological effects. Cancer Research 1987; 47: 597–601
   PubMed Web of Science ®Google Scholar
• Chaplin D.J., Acker B. The effect of hydralazine on the tumour cytotoxicity of the hypoxic cell cytotoxin RSU1069. Evidence for therapeutic gain. International Journal of Radiation Oncology, Biology and Physics 1987; 13: 579–585
   PubMed Web of Science ®Google Scholar
• Chaplin D.J., Acker B.D., Horsman M.R. Reduction in tumour blood flow by vasoactive drugs: A role in cancer therapy. Biomedica et Biochimica Acta 1989a; 48: 255–259
   PubMedGoogle Scholar
• Chaplin D.J., Acker B., Olive P.L. Potentiation of the tumour cytotoxicity of melphalan by vasodilating drugs. International Journal of Radiation Oncology, Biology and Physics 1989b; 16: 1131–1135
   PubMed Web of Science ®Google Scholar
• Chaplin D.J., Horsman M.R., Trotter M.J. Effect of nicotinamide on the microregional heterogenity of oxygen delivery within a murine tumour. Journal of the National Cancer Institute 1990; 82: 672–676
   PubMedGoogle Scholar
• Chaplin D.J., Horsman M.R., Aoki D.S. Nicotinamide, fluosol DA and Carbogen: A strategy to reoxygenate acutely and chronically hypoxic cells in vivo. British Journal of Cancer 1991a; 63: 109–113
   PubMed Web of Science ®Google Scholar
• Chaplin D.J., Horsman M.R., Peters C.E., Trotter M.J. Tumour blood flow and its modulation: Implications for bioreductive drug activity in vivo. NATO advanced research seminar series: Selective Activation of Drugs by Redox Processes. Plenum, New York 1991b; 325–336, In
   Google Scholar
• Ching L.M., Baguley B.C. Induction of natural killer cell activity by the antitumour compound flavone acetic acid (NSC 347512). European Journal of Cancer and Clinical Oncology 1987; 23: 1047–1050
   PubMedGoogle Scholar
• Ciba Foundation Symposium 131. Tumour Necrosis Factor and Related Cytokines. H. Wiley, London 1987
   Google Scholar
• Coley W.B. The treatment of malignant tumours by repeated inoculations of erysipelais, with a report of ten original cases. American Journal of Medical Science 1893; 105: 488–511
   Google Scholar
• Das M., Mukhtar H., Greenspan E.R., Bickers D.R. Photoenhancement of lipid peroxidation associated with the generation of reactive oxygen species in hepatic microsomes of hematoporphrin derivative treated rats. Cancer Research 1985; 45: 6328–6330
   PubMedGoogle Scholar
• Denekamp J. Vasculature as a target for tumour therapy. Progress in Applied Microcirculation 1984; 4: 28–38
   Google Scholar
• Denekamp J., Hill S.A., Hobson B. Vascular occlusion and tumour cell death. European Journal of Cancer 1983; 19: 271–275
   Google Scholar
• Dische S. Hyperbaric oxygen: The Medical Research Council trials and their clinical significance. British Journal of Radiology 1979; 31: 888–894
   Google Scholar
• Doll D.C., Ringenberg Q.S., Yorbro Y.W. Vascular toxicity associated with antineoplatic agents. Journal of Clinical Oncology 1986; 4: 1405–1417
   PubMed Web of Science ®Google Scholar
• Dougherty T.J. Photosensitizers: therapy and detection of malignant tumours. Photochemistry and Photobiology 1987; 45: 879–889
   PubMed Web of Science ®Google Scholar
• Eddy H.A. Alteration in tumour microvasculature during hyperthermia. Radiology 1980; 137: 515–521
   PubMed Web of Science ®Google Scholar
• Eddy H.A., Sutherland R.M., Chromelewski G. Tumour microvascular response: hyperthermia and radiation combinations. National Cancer Institute Monograph 1982; 61: 225–229
   Google Scholar
• Ekelund L., Lunderquist A. Pharmacoangiography with angiotensin. Radiology 1974; 110: 533–540
   PubMedGoogle Scholar
• Evans S., Matthews W., Perry R., Fraker D., Norton J., Pass H.I. Effect of photodynamic therapy on tumour necrosis factor production by murine macrophages. Journal of the National Cancer Institute 1990; 82: 34–39
   PubMed Web of Science ®Google Scholar
• Evelhoch J.L., Bissey M.C., Chabot G.G., Simpson N.E., McCoy C.L., Helilbrun L.K., Corbett T.H. Flavone acetic acid (NSC 347512)—induced modulation of murine tumour physiology monitored by in vivo nuclear magnetic resonance spectroscopy. Cancer Research 1988; 48: 4749–4755
   PubMed Web of Science ®Google Scholar
• Fingar V.H., Henderson B.W. Drug and light dose dependence of photodynamic therapy: a study of tumour and normal tissue response. Photochemistry and Photobiology 1987; 46: 837–841
   PubMed Web of Science ®Google Scholar
• Fingar V.H., Wieman T.J., Doak K.W. Role of thromboxane and prostacyclin release on photodynamic therapy-induced tumour destruction. Cancer Research 1990; 50: 2599–2603
   PubMed Web of Science ®Google Scholar
• Finlay G.J., Smith G.P., Fray L.M., Baguley B.C. Effect of flavone acetic acid (NSC 3475123) on Lewis lung carcinoma; evidence for an indirect effect. Journal of the National Cancer Institute 1988; 80: 241–245
   PubMed Web of Science ®Google Scholar
• Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? GHA Clowes Memorial Award Lecture. Cancer Research 1986; 46: 467–473
   PubMed Web of Science ®Google Scholar
• Gomer C.J., Dougherty T.J. Determination of 3H and 14C—hemtroporhyrin derivative distribution in malignant and normal tissue. Cancer Research 1979; 39: 146–151
   PubMed Web of Science ®Google Scholar
• Grady E.D., Auda S.P., Cheek W.V. Vascoconstrictors to improve localisation of radioactive microspheres in the treatment of liver cancer. Journal of the Medical Association 1981; 70: 791–795
   Google Scholar
• Henk J.M., Smith C.W. Radiotherapy and hyperbaric oxygen in head and neck cancer. Lancet 1977; 2: 104–105
   PubMedGoogle Scholar
• Hobson B., Denekamp J. Endothelial proliferation in tumours and normal tissues: continuous labelling studies. British Journal of Cancer 1984; 49: 405–413
   PubMed Web of Science ®Google Scholar
• Hopewell, J.W. The importance of vascular effects in the development of late radiation damage. Proceedings of the Sixth International Congress of Radiation Research, S. Okhada, et al. Japanese Association for Radiation Research, Tokyo 1979; 680–687
   Google Scholar
• Hornung E.R., Young H.A., Urba W.J., Wiltrout R.H. Immunomodulation of natural killer cell activity by flavone acetic acid: occurrence via induction of interferon α/β. Journal of the National Cancer Institute 1988; 80: 1226–1231
   PubMedGoogle Scholar
• Horsman M.R., Chaplin D.J., Brown J.M. Radiosensitisation by nicotinamide in vivo: a greater enhancement of tumour damage compared to that of normal tissues. Radiation Research 1987; 109: 479–489
   PubMed Web of Science ®Google Scholar
• Horsman M.R., Chaplin D.J., Brown J.M. Tumour radiosensitisation by nicotinamide: A result of improved perfusion and oxygenation. Radiation Research 1989a; 118: 139–150
   PubMed Web of Science ®Google Scholar
• Horsman M.R., Christensen K.L., Overgaard J. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo. International Journal of Hyperthermia 1989b; 5: 123–136
   PubMed Web of Science ®Google Scholar
• Horsman M.R., Winther J. Vascular effects of photodynamic therapy in an intraocular retinoblastoma-like tumour. Acta Oncologica 1989; 28: 693–697
   PubMed Web of Science ®Google Scholar
• Jain R.K. Delivery of novel therapeutic agents in tumours: physiological barriers and strategies. Journal of the National Cancer Institute 1989; 81: 570–576
   PubMed Web of Science ®Google Scholar
• Jain R.K., Ward Hartley K. Tumour blood flow—characterisation, modifications and a role in hyperthermia. IEEE Transaction Sonics, Ultrasonics. 1984; 504–526, SU-31
   Google Scholar
• Jirtle R.E. Chemical modification of tumour blood flow. International Journal of Hyperthermia 1988; 4: 355–371
   PubMed Web of Science ®Google Scholar
• Jirtle R.L., Clifton K.H., Rankin J.H.G. Effects of several vascoactive drugs on the vascular resistance of MT-W9B tumours in W/Fu rats. Cancer Research 1978; 38: 2385–2390
   PubMed Web of Science ®Google Scholar
• Kallinowski F, Schlenger K.H., Runkel S., Kloes M., Stohrer M., Okunieff P., Vaupel P. Blood flow, metabolism, cellular microenvironment and growth rate of human tumour xenografts. Cancer Research 1989a; 49: 3759–3764
   PubMed Web of Science ®Google Scholar
• Kallinowski F., Schaefer C., Tyler G., Vaupel P. In vivo targets of recombinant human tumour necrosis factor α, blood flow, oxygen consumption and growth of isotransplanted rat tumours. British Journal of Cancer 1989b; 60: 555–560
   PubMed Web of Science ®Google Scholar
• Kerr D.J., Maughan T., Newlands E., Rustin G., Bleehan N.M., Lewis C., Kaye S.B. Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma. British Journal of Cancer 1989; 60: 104–106
   PubMed Web of Science ®Google Scholar
• Kessel D. Hematoporhpyrin and HPD. Photophysics, Photochemistry and phototherapy. Photochemistry and Photobiology 1984; 39: 851–859
   PubMed Web of Science ®Google Scholar
• Kletzel M., Jaffe N. Systemic hypertension: a complication of intrarterial cisdiammine dichloroplatinum II infusion. Cancer 1981; 47: 245–247
   PubMedGoogle Scholar
• Korbelik, M., Krosl, G., Chaplin, D.J. Photofrin uptake by Murine macrophages. Cancer Research, In press, 1991; 51
   PubMedGoogle Scholar
• Kuroiwa T., Aoki K., Hasuda K., Baba T. Efficacy of two-route chemotherapy using cis-diammine dichloroplatinum (II) and its antidote sodium thiosulphate in combination with angiotensin II in a rat limb tumour. Cancer Research 1987; 47: 3618–3623
   PubMed Web of Science ®Google Scholar
• Mahadevan V., Malik S.T.A., Meager A., Fiers W., Lewis G.P., Hart I.R. Role of tumour necrosis factor in flavone acetic acid induced tumour vascular shutdown. Cancer Research 1990; 50: 5537–5542
   PubMed Web of Science ®Google Scholar
• Minchinton A.I., Durand R.E., Chaplin D.J. Intermittent blood flow in the KHT sarcoma flow cytometric studies using Hoechst 33342. British Journal of Cancer 1990; 62: 195–200
   PubMed Web of Science ®Google Scholar
• Moan J. Porphyrin, photosensitization and phototherapy. Photochemistry and Photobiology 1986; 43: 681–690
   PubMed Web of Science ®Google Scholar
• Moan J., Sommer S. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NH1K 3025 cells. Cancer Research 1985; 45: 1608–1610
   PubMed Web of Science ®Google Scholar
• Murray J.C., Randhawa V., Denekamp J. The effects of melphalan and misonidazole on the vasculature of a murine sarcoma. British Journal of Cancer 1987; 55: 233–238
   PubMedGoogle Scholar
• Murray J.C., Smith K.A., Thurston G. Flavone acetic acid induces a coagulopathy in mice. British Journal of Cancer 1989; 60: 729–734
   PubMed Web of Science ®Google Scholar
• Murray J.C., Thurston G., Smith K.A., Denekamp J., Stern D. Flavone acetic acid: is tumour endothelium a primary target?. British Journal of Cancer 1990; 62: 516–516
   Google Scholar
• Nelson J.S., Liaw L.H., Orenstein A., Roberts W.G., Berns M.W. Mechanism of tumour destruction following photodynamic therapy with hematoporphyrin derivative chlorin and pthalocyanine. Journal of the National Cancer Institute 1988; 80: 1599–1605
   PubMedGoogle Scholar
• Old L.J. Tumour necrosis factor (TNF). Science 1985; 230: 630–632
   PubMed Web of Science ®Google Scholar
• Peters C.E., Trotter M.J., Chaplin D.J. Early spatial and temporal changes in tumour perfusion after administration of Flavone acetic acid. International Journal of Radiation Biology 1991; 60: 339–346
   Google Scholar
• Pober J.S. Effects of tumour necrosis factor and related cytokines on vascular endothelial cells. Tumour Necrosis Factor and Related Cytokines. Ciba Foundation Symposium 131. Wiley, Chichester 1987; 170–184
   Google Scholar
• Pober J.S., Cotran R.S. Cytokines and endothelial cell biology. Physiology Reviews 1990; 70: 427–451
   PubMed Web of Science ®Google Scholar
• Rowell N.P., Flower M.A., McCready V.R., Cronin B., Horwich A. The effect of single dose oral hydralazine on blood flow through human lung tumours. Radiotherapy and Oncology 1990; 18: 283–292
   PubMed Web of Science ®Google Scholar
• Sato N., Goto T., Haranaka K., Satomi N., Nanuchi H., Mano-Hirano Y., Sawaski Y. Actions of tumour necrosis factor on cultured vascular endothelial cells, morphological modulation, growth inhibition and cytotoxicity. Journal of the National Cancer Institute 1986; 76: 1113–1121
   PubMed Web of Science ®Google Scholar
• Schroyens W.A., Dodion P.F., Sanders C., Loos M., Dethier N.E., Delforge A.R., Stryckmans T.A., Kenis Y. In vitro chemosensitivity testing of flavone acetic acid (LM975, NSC347512) and its diethylaminoethyl ester derivative (LM 985 NSC 293015). European Journal of Cancer and Clinical Oncology 1987; 23: 1135–1139
   PubMedGoogle Scholar
• Selman S.H., Kreimer-Birnbaum M., Keck R.W., Milligan A.J., Goldblatt P.J., Britton S. Correlation of tumour blood flow to tumour regression after hepatoporphyrin-derivative (HPD) photodynamic therapy to transplantable bladder tumours. Advances in Experimental Medicine and Biology 1985; 193: 97–103
   PubMedGoogle Scholar
• Sevick E.M., Jain R.K. Geometric resistance to blood flow in solid tumours perfused ex vivo: effects of tumour size and perfusion pressure. Cancer Research 1989; 49: 3506–3512
   PubMed Web of Science ®Google Scholar
• Siemann D.W. Enhancement of chemotherapy and nitroimidazole-induced chemo-potentiation by the vasoactive agent hydralazine. British Journal of Cancer 1990; 62: 348–353
   PubMed Web of Science ®Google Scholar
• Song C.W. Effect of local hyperthermia on blood flow and microenvironment. Cancer Research 1984; 44: 4721S–4730S, (Suppl.)
   PubMed Web of Science ®Google Scholar
• Star W.M., Marijnissen H.P.A., Vander, Berg-Block A.E., Versteeg J.A.C., Franken K.A.P., Reinhold H.S. Destruction of rat mammary tumour and normal tissue microcirculation by hematoporphrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Research 1986; 46: 2532–2540
   PubMed Web of Science ®Google Scholar
• Stratford I.J., Adams G.E., Godden J., Nolan J., Howells N., Timpson N. Potential of the anti-tumour effect of melphalan by the vasoactive agent hydralazine. British Journal of Cancer 1988; 58: 122–127
   PubMed Web of Science ®Google Scholar
• Suzuki M., Hori K., Abe I., Saito S., Sato H. A new approach of cancer chemotherapy: selective enhancement of tumour blood flow with angiotensin II. Journal of the National Cancer Institute 1981; 67: 663–669
   PubMed Web of Science ®Google Scholar
• Takematsu H., Tomita Y., Kato T. Angiotensin induced hypertension and chemotherapy for multiple lesions of malignant melanoma. British Journal of Dermatology 1985; 113: 463–485
   PubMedGoogle Scholar
• Teicher B.A., Rose C.M. Perfluorochemical emulsions can increase tumour radiosensitivity. Science 1984; 223: 934–936
   PubMed Web of Science ®Google Scholar
• Trotter M.J., Chaplin D.J., Durand R.E., Olive P.L. The use of fluorescent probes to identify regions of transient prefusion and oxygenation. International Journal of Radiation Oncology, Biology and Physics 1989a; 16: 931–935
   PubMed Web of Science ®Google Scholar
• Trotter M.J., Acker B.D., Chaplin D.J. Histological evidence for non-perfused vasculature in a murine tumour following hydralazine administration. International Journal of Radiation, Oncology, Biology and Physics 1989b; 17: 785–789
   PubMedGoogle Scholar
• Trotter M.J., Chaplin D.J., Olive P.L. Possible mechanisms for intermittent blood flow in the murine SCCVII carcinoma. International Journal of Radiation Biology 1991; 60: 139–146
   PubMed Web of Science ®Google Scholar
• Vaupel P., Kallinowski F. Physiological effects of hyperthermia. Hyperthermia and the Therapy of Malignant Tumours, C. Streffer. Springer Verlag, Berlin 1987; 71–109
   Google Scholar
• Vaupel P., Frinak S., Bicher H.I. Heterogenous oxygen partial pressure and pH distribution in C3H mouse mammary adenocarcinoma. Cancer Research 1981; 41: 2008–2013
   PubMed Web of Science ®Google Scholar
• Vaupel P., Mueller Klieser W., Otte J., Manz R., Kallinowski F. Blood flow, tissue oxygenation and pH distribution in malignant tumours upon localised hyperthermia. Strahlentherapie 1983; 159: 73–81
   PubMedGoogle Scholar
• Vorhees W.D., Babbs C.F. Hydralazine-enhanced selective heating of transmissable venereal tumour implants in dogs. European Journal of Cancer and Clinical Oncology 1982; 19: 1027–1033
   Google Scholar
• Watanabe N., Niitsu Y., Umeno H., Kuriyana H., Neda H., Yamauchi Y., Maeda M., Urushizaki I. Toxic effect of tumour necrosis factor on tumour vasculature in mice. Cancer Research 1988; 48: 2179–2183
   PubMed Web of Science ®Google Scholar
• Weibel E.R. The Pathway for Oxygen, Structure and Function in the Mammalian Respiratory System. Harvard University Press, Cambridge, MA 1984
   Google Scholar
• Weishaupt K.R., Gomer C.J., Dougherty T.J. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumour. Cancer Research 1976; 36: 2326–2329
   PubMed Web of Science ®Google Scholar
• Weiman T.J., Mang T.S., Fingar V.H., Hill T.G., Reed M.W., Corey T.S., Nguyen V.Q., Render E.R. The effect of photodynamic therapy on blood flow in normal and tumour vessels. Surgery 1988; 104: 512–417
   PubMedGoogle Scholar
• Winther J. Photodynamic therapy effect in an intraocular retinoblastoma-like tumour assessed by an in vitro colony forming assay. British Journal of Cancer 1989; 59: 869–872
   PubMedGoogle Scholar
• Wood P.J., Hirst D.G. Modification of tumour response to calcium antagonists in the SCCVII/St tumour implanted at two different sites. International Journal of Radiation Biology 1989; 56: 355–367
   PubMed Web of Science ®Google Scholar
• Zwi L.J., Baguley B.C., Gavin J.B., Wilson W.R. Blood flow failure as a major determinant in the anti-tumour action of flavone acetic acid. Journal of the National Cancer Institute 1989; 81: 1005–1013
   PubMed Web of Science ®Google Scholar
• Zwi L.J., Baguley B.C., Gavin J.B., Wilson W.R. The use of vascularised spheroids to investigate the action of flavone acetic acid on tumour blood vessels. British Journal of Cancer 1990; 62: 231–237
   PubMed Web of Science ®Google Scholar